Completed
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change
NCT01317004
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Novartis Investigative Site Ancona, AN, Italy
- Novartis Investigative Site Ponderano, BI, Italy
- Novartis Investigative Site Caltanissetta, CL, Italy
- Novartis Investigative Site Cuneo, CN, Italy